Since the majority of the ERα-negative breast cancer samples included in our cohort were also PR-negative and high grade [24,52,53], there was a limited capacity to find any association between expression of marker genes and those clinical variables, even when using the ERα-negative cell line MDA-MB-231. The gene discussed is ESR1; the disease is breast cancer.